TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ENGN

enGene Holdings Inc.

Healthcare · Biotechnology

2.00$ +0.5% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

enGene Holdings Inc. (ENGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 288 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ENGN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
87 93 274 267 311 286 267 246 221 337 308 288
85 90 270 263 247 222 228 211 201 289 270 278
82 86 265 258 173 62 58 33 50 37 30 41
82 86 265 258 238 214 217 202 194 276 258 266
2.3 1.1 1.2 0.2 1.0 0.4 0.5 0.7 2.2 1.2 2.9 2.9
0.1 0.1 0.1 0.1 – – – – – – – –
14 31 31 37 39 36 39 45 54 56 52 58
5.3 6.9 6.3 13 15 13 18 20 32 25 21 27
0.6 0.4 0.4 1.8 1.1 2.1 4.0 6.9 10 2.5 2.5 2.4
1.2 1.3 0.2 2.9 1.4 2.6 1.6 2.4 6.7 2.4 1.8 2.5
23 23 23 22 22 22 20 18 15 25 25 25
72 62 243 230 273 250 227 201 168 282 255 230
-200 -210 -225 -239 -255 -279 -305 -334 -372 -402 -432 -465
31 23 39 44 45 51 51 51 51 67 70 70

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?